Healthcare & Medical Devices Global On demand · 24-48h

Global Medical Non-invasive Lithotripter Market Strategic Research Report

Global Medical Non-invasive Lithotripter Market Strategic Re…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medical Non-invasive Lithotripter Market
$1.23B2025
5.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Mobile, Fixed

By Application: Kidney Stones, Pancreas Stones, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: ELMED MEDICAL, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Medispec, NOVAMEDTEK, Siemens Healthcare S.A.E., Dornier MedTech, Shenzhen Huikang Medical Apparatus Co., Ltd., Jingcheng Medical, Shenzhen Hyde Medical Equipment

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 94 pages
Market size 2025
$1.23B
Billion USD
Forecast CAGR
5.7%
2025-2032
Forecast 2032
$1.8B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Medical Non-invasive Lithotripter market size is predicted to grow from US$ 1,226 million in 2025 to US$ 1,796 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

A medical non-invasive lithotripter is a medical device used to perform extracorporeal shock wave lithotripsy (ESWL), a non-invasive procedure for breaking down kidney stones, gallstones, and other calculi or concretions in the body. The lithotripter generates shock waves that are directed at the location of the stone(s) inside the patient"s body, typically using focused ultrasound or electromagnetic waves, without the need for surgical incisions.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Medical Non-invasive Lithotripter market?

What factors are driving Medical Non-invasive Lithotripter market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Medical Non-invasive Lithotripter market opportunities vary by end market size?

How does Medical Non-invasive Lithotripter break out by Type, by Application?

This report presents a comprehensive overview of the global Medical Non-invasive Lithotripter market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Mobile
  • Fixed

Segment by Application

  • Kidney Stones
  • Pancreas Stones
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medical Non-invasive Lithotripter market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Kidney Stones, Pancreas Stones, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medical Non-invasive Lithotripter Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.23B
2025
Forecast
$1.8B
2032
CAGR
5.7%
2025–2032
Regiões
5
global
Key companies
ELMED MEDICALInceler Medikal Co. Ltd.STORZ MEDICAL AGMedispecNOVAMEDTEKSiemens Healthcare S.A.E.Dornier MedTechShenzhen Huikang Medical Apparatus Co., Ltd.
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
MobileFixed
By Application
Kidney StonesPancreas StonesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Mobile
  • 3.1.3 Fixed
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Kidney Stones
  • 4.1.3 Pancreas Stones
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 ELMED MEDICAL
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Inceler Medikal Co. Ltd.
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 STORZ MEDICAL AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Medispec
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 NOVAMEDTEK
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Siemens Healthcare S.A.E.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Dornier MedTech
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Shenzhen Huikang Medical Apparatus Co., Ltd.
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Jingcheng Medical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shenzhen Hyde Medical Equipment
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Medical Non-invasive Lithotripter market size?
The global Medical Non-invasive Lithotripter market is estimated at US$ 1.23 billion in 2025 (base year) and is projected to reach US$ 1.8 billion by 2032.
What growth rate is expected for the Medical Non-invasive Lithotripter market through 2032?
The market is expected to grow at a CAGR of 5.7% from 2026 to 2032, expanding from US$ 1.23 billion in 2025 to US$ 1.8 billion in 2032, roughly 1.5 times its base-year value.
How is Medical Non-invasive Lithotripter defined?
A medical non-invasive lithotripter is a medical device used to perform extracorporeal shock wave lithotripsy (ESWL), a non-invasive procedure for breaking down kidney stones, gallstones, and other calculi or concretions in the body. The lithotripter generates shock waves that are directed at the location of the stone(s) inside the patient"s body, typically using focused ultrasound or electromagnetic waves, without the need for surgical incisions.
How is the Medical Non-invasive Lithotripter market segmented by type?
By type, the market is segmented into Mobile and Fixed.
What are the key applications of Medical Non-invasive Lithotripter?
Key applications covered include Kidney Stones, Pancreas Stones and Other.
Which companies are profiled in the Medical Non-invasive Lithotripter market report?
Key players profiled include ELMED MEDICAL, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Medispec, NOVAMEDTEK, Siemens Healthcare S.A.E., Dornier MedTech and Shenzhen Huikang Medical Apparatus Co., among 10 companies covered in total.
What geographies does the Medical Non-invasive Lithotripter market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Medical Non-invasive Lithotripter?
The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Who should buy the Medical Non-invasive Lithotripter market report?
The report is intended for manufacturers and solution providers, distributors and end users in Kidney Stones, Pancreas Stones and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medical Non-invasive Lithotripter market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.